Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
RemedyRePack Inc.

RemedyRePack Inc. Recalls

All product recalls associated with RemedyRePack Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Apr 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–5 of 5 recalls

Clindamycin HCl Capsules (RemedyRePack) - CGMP Issues (2025)

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Class IIModerate

FDAApr 22, 2025FL, PA, VA• RemedyRePack Inc.

Clindamycin HCl Capsules (RemedyRepack) – CGMP Issues (2025)

CGMP Deviations

Class IIModerate

FDAMar 24, 2025PA• RemedyRepack Inc.

Duloxetine Capsules 60mg (RemedyRepack) – CGMP Impurity Limit (2024)

CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

Class IIModerate

FDA

Dec 2, 2024

Nationwide

• RemedyRepack Inc.

Pyrazinamide Tablet 500mg (RemedyRepack) – Quality Program Issue (2023)

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Class IIModerate

FDAMay 1, 2023IN, PA• RemedyRepack Inc.

Ketotifen Fumarate Eye Drops (RemedyRepack) – Quality Program Issue (2023)

Class IIModerate

FDAMay 1, 2023IN, PA• RemedyRepack Inc.